Related references
Note: Only part of the references are listed.Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement
Lesley A. Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use
Jayne F. Tierney et al.
PLOS MEDICINE (2015)
Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol
Hanne Trap Wolf et al.
AIMS PUBLIC HEALTH (2015)
Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010
Hannah Blencowe et al.
PEDIATRIC RESEARCH (2013)
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA) - study protocol
Caroline A. Crowther et al.
BMC PREGNANCY AND CHILDBIRTH (2013)
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
Emily S. Bain et al.
BMC PREGNANCY AND CHILDBIRTH (2013)
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
Hannah Blencowe et al.
LANCET (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE)
C. A. Crowther et al.
SYSTEMATIC REVIEWS (2012)
Magnesium Sulphate for Fetal Neuroprotection
Laura Magee et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2011)
Committee Opinion No. 455: Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection
OBSTETRICS AND GYNECOLOGY (2010)
Preterm birth 3 - An overview of mortality and sequelae of preterm birth from infancy to adulthood
Saroj Saigal et al.
LANCET (2008)
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy
Dwight J. Rouse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Magnesium sulphate given before very-preterm birth to protect infant brain:: the randomised controlled PREMAG trial
S. Marret et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Effect of magnesium sulfate given for neuroprotection before preterm birth - A randomized controlled trial
CA Crowther et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants
R Mittendorf et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
L Duley et al.
LANCET (2002)
Share Paper
